CURRICULUM VITAE

Samer Gawrieh MD
Associate Professor
Department of Medicine
Division of Gastroenterology

OFFICE ADDRESS:
Froedtert East Clinics
9200 W Wisconsin Ave
Milwaukee, WI 53226

EDUCATION:
1990 - 1996 Aleppo University School of Medicine, Aleppo, Syria

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1998 - 2001 Internal Medicine, Cook County Hospital, Chicago, IL
2001 - 2004 Gastroenterology, Medical College of Wisconsin, Milwaukee, WI
- 2004 Transplant Hepatology, Mayo Clinic, Rochester, MN

FACULTY APPOINTMENTS:
4/2010 - Present Medical Director of Liver Transplantation, Medical College of Wisconsin, Milwaukee, WI
7/2011 - Present Associate Professor of Medicine, Department of Medicine, Division of Gastroenterology and Hepatology, Medical College of Wisconsin, Milwaukee, WI

ADMINISTRATIVE APPOINTMENTS:
7/2009 - Present Member, Internal Review Board, Medical College of Wisconsin, Milwaukee, WI
4/2010 - Present Medical Director of Liver Transplantation, Medical College of Wisconsin, Milwaukee, WI

EDUCATIONAL ADMINISTRATIVE APPOINTMENTS:
2007 - Present Co-Chairman, Medical Advisory Committee, American Liver Foundation, Wisconsin's Chapter, WI

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
4/2010 - Present Medical Director of Liver Transplantation, Medical College of Wisconsin, Milwaukee, WI

HOSPITAL STAFF PRIVILEGES:
Zablocki VA Medical Center, Milwaukee , WI
Froedtert Memorial Lutheran Hospital, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Certificates
Issued By Issue DateExpiration
Educational Commission for Foreign Medical Graduates (ECFMG).
1997
None
American Board of Internal Medicine
2001
2011
American Board of Internal Medicine/Gastroenterology.
2004
2014
American Board of Internal Medicine / Transplant Hepatology
2008
2018
 
Licensure
Number Issue DateExpiration
Wisconsin License
2001
10/31/2009
USMLE Step 1
None
USMLE Step 2
None
USMLE Step 3
None
 
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
American Association for the Study of Liver Disease (AASLD) (Member)
American Gastroenterological Association (AGA) (Member)
Milwaukee Gastroenterological Society (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
Hepatology
BMC Research Notes
Physiological Genomics

COMMITTEE SERVICE:
Medical College
2004 - Present Assistant Professor of Medicine, Division of Gastroenterology and Hepatology, Department of Medicine, Medical College of Wisconsin
2007 - Present Co-Chairman, Medical Advisory Committee, Wisconsin’s Chapter, Medical Advisory Committee
7/2009 - Present Internal Review Board, Medical College of Wisconsin.
 

BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Gawrieh S, Knoedler DM, Saeian K, Wallace JR, Komorowski RA. Effects of interventions on intra- and inter-observer agreement on interpretation of non-alcoholic fatty liver disease histology. Ann Diagn Pathol 2010 Nov 23. [Epub ahead of print].
2. Gawrieh S, Mersha T, Carless M, Wallace J, Komorowski R, Kleiner DE, Andris D, Makladi B, Cole R, Charlton M, Curran J, Dyer T, Charlesworth J, Wilke R, Blangero J, Kissebah A, Olivier M. Hepatic Gene Networks in Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. Obes Surg. 2010 May 16. [Epub ahead of print].
3. Ulitsky A, Ananthakrishnan AN, Komorowski R, Wallace J, Surapaneni SN, Franco J, Saeian K, Gawrieh S. A Non-Invasive Clinical Scoring Model Predicts Risk of Non-Alcoholic Steatohepatitis in Morbidly Obese Patients. Obes Surg. 2010 Mar 25. [Epub ahead of print].
4. Smith EM, Zhang Y, Baye TM, Gawrieh S, Cole R, Blangero J, Carless MA, Curran JE, Dyer TD, Abraham LJ, Moses EK, Kissebah AH, Martin LJ, and Olivier M. INSIG1 influences obesity-related hypertriglyceridemia in humans . J Lipid Res. 2010 Apr;51(4):701-8..
5. Charlton M, Angulo P, Chalasani N, Merriman R, Viker K, Charatcharoenwitthaya P, Sanderson S, Gawrieh S, Krishnan A, Lindor K. Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease. Hepatology. 2007 Dec 27;47(2):484-492.
6. Gawrieh S, Carroll T, Hogan WJ, Soergel KH, Shaker R. Swallow syncope in association with schatzki ring and hypertensive esophageal peristalsis: report of three cases and review of the literature. Dysphagia. 2005 Fall;20(4):273-7
7. Gawrieh S, Papouchado BG, Burgart LJ, Kobayashi S, Charlton MR, Gores GJ. Early Hepatic Stellate Cell Activation Predicts Severe Hepatitis C Recurrence after Liver Transplantation. Liver Transpl. 2005 Oct;11(10):1207-13.
8. Gawrieh S, Massey BT, Komorowski RA. scalp metastases as the first manifestation of pancreatic cancer. Dig Dis Sci. 2002 Jul;47(7):1469-71.
 
Books, Chapters, and Reviews
1. Gawrieh S, Shaker R. A. Pilotto, P. Malfertheiner and Peter R. Holt. Aging and the Gastrointestinal Tract, Book Review. Gastroenterology. 2007 Mar; 132(3):1196.
2. Gawrieh S, Opara EC, Koch TR. Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Investig Med. 2004 Dec;52(8):506-14.
3. Kaplan MS, Gawrieh S, Cotler SJ, Jensen DM. Neutralizing antibodies in hepatitis c virus infection: a review of immunological and clinical characteristics. Gastroenterology 2003 Aug;125(2):597-604.
4. Gawrieh S, Shaker, R. Medical management of nocturnal symptoms of gastroesophageal reflux disease in the elderly. Drugs Aging 2003:20(7)509-16.
5. Gawrieh S, Shaker R. Peripheral mechanisms affecting the lower esophageal sphincter tone. Gastroenterol Clin North Am. 2002 Dec;31(4 Suppl):S21-33.
 
Editorials, Letters to Editor, Other
1. Gawrieh S, Shaker R. Treatment of actively bleeding Mallory-Weiss syndrome: epinephrine injection or band ligation? Curr Gastroenterol Rep. 2005 Jun;7(3):175.
2. Gawrieh S, Shaker R. Variceal band ligation versus propranolol for primary prophylaxis of variceal bleeding in cirrhosis. Curr Gastroenterol Rep. 2005 Jun;7(3):175-6.
3. Gawrieh S, Saeian K. Management of esophageal varices: an update from Digestive Disease Week and American Association for the Study of Liver Diseases 2003. Curr Gastroenterol Rep. 2004 Jun;6(3):206-9.
4. Gawrieh S, Shaker R. Treatment options for eosinophilic esophagitis: montelukast. Curr Gastroenterol Rep. 2004 Jun;6(3):190.
5. Gawrieh S, Shaker R. Treatment options for eosinophilic esophagitis: elemental diet.Curr Gastroenterol Rep. 2004 Jun;6(3):189.
6. Gawrieh S, Koch TR. Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats. Rodriguez-Ortigosa CM, Cincu RN, Sanz S, et al.; Supplemental bile salts: the good, the bad. Gut 2002;50:701-6. Am J Gastroenterol. 2003 Apr;98(4):934-935.
 
Abstracts
1. Gawrieh, S, Hogan, WJ, Caroll, T, and Shaker, R. 2002. Deglutitive syncope associated with esophageal dysphagia. Gastroenterology: 122: A362. Presented as a poster at DDW, San Francisco, CA - 2002.
2. Gawrieh, S, Prajapati, DN, Saeian, K, Varma, RR, Franco, J, Knox, JF, Kern, M, and Binion, DG. 2002. Prevalence and patterns of liver tests abnormalities in patients with inflammatory bowel Disease. Hepatology: 36(4): A334. Presented as a poster in AASLD Meeting, Boston, MA - 2002.
3. Gawrieh, S, Jean, MC, and Massey, BT. 2003. Not just a failure to relax: Timing and magnitude of lower esophageal sphincter after-contractions also contribute to esophageal outflow obstruction in achalasia. Gastroenterology: 124(4): A161. Presented as a Poster of Distinction for DDW, Orlando, FL - 2003.
4. Gawrieh, S, Rosado, B, Lindor, K, and Charlton, MR. 2004. Adipokine levels are predictive of histology in patients with non-alcoholic fatty liver disease. Hepatology: 40(4): A270. Selected for Oral Presentation for AASLD Presidential Plenary Session, Boston, MA - 2004.
5. Gawrieh, S, Papouchado, BG, Kobayashi, S, Charlton, MR, and Gores, GJ. 2004. Mesenchymal hepatic stellate cells activation index predicts progressive hepatitis C virus recurrence after liver transplantation. Hepatology: 40(4): A242. Selected for Oral Presentation for AASLD Parallel Session, Boston, MA - 2004.
6. Gawrieh, S, Eckert, J, Komorowski, R, Wallace, J, Kissebah, A, and Olivier, M. 2006. Genetic Variation of Protein Tyrosine Phosphatase 1 Beta in Non-Alcoholic Fatty Liver Disease. Presented as a poster at Keystone Symposia, Big Sky, MT - 2006.
7. Charlton, MR, Angulo Hernandez, P, Charatcharoenwitthaya, P, Burgart, L, Gawrieh S, Lindor, K, Viker, K, and Krishnan, A. 2006. Low Circulating DHEA Levels in Severe Non-alcoholic Fatty Liver Disease - A Potential Metabolic Basis of Disease Progression. Gastroenterology: 130(4): A22. Selected for Oral Presentation for Digestive Disease Week, Los Angeles, CA - 2006.
8. Gawrieh, S, Eckert, J, Komorowski, R, Cole, R, Wallace, J, Kissebah, A, and Olivier, M. 2006. A Protein Tyrosine Phosphatase 1 Beta (PTP-1B) Risk Haplotype is Associated with Non- Alcoholic Steatohepatitis in Females. Hepatology: 44(4): A656.
9. Katopes, CP, Surapaneni, SN, Komorowski, R, Behmaram, B, Wallace, J, Nuttleman, P, Franco, J, Varma, R, Massoud, O, Saeian, K, Gawrieh, S. 2007. Variability in the histologic interpretation of non-alcoholic fatty liver disease. Gastroenterology: 132(4): A2160.
10. Gawrieh S, Marion M, Smith K, Komorowski R, Wallace J, Nuttleman P, Andris D, Kissebah A, Langefeld C, Olivier M. 2007. Genetic variation in the peroxisome proliferator activated receptor-gamma gene is associated with NAFLD and its histological phenotypes. Am J Gastro, 102, Suppl 2: 5246. Presented as a poster at The American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA - 2007.
11. Surapaneni S, Katopes C, Wallace J, Nuttleman P, Andris D, Behnaz B, Komorowski R, Franco J, Varma R, Massoud O, Saeian K, Gawrieh S. 2007. Prediction of histology in nonalcoholic fatty liver disease: do medications matter?. Am J Gastro, 102, Suppl 2: 5242. Presented as a poster at The American College of Gastroenterology Annual Scientific Meeting, Philadelphia, PA - 2007.
12. Meier K, Komorowski R, Wallace J, Nuttleman P, Andris D, Gawrieh S. 2007. Liver Pathology in Patients With Suspected Nonalcoholic Fatty Liver Disease. Am J Clin Pathol 2007, 128:708.Presented as a poster at The American Society for Clinical Pathology Annual Meeting, New Orleans, LA - 2007.
13. Gawrieh S, Wallace J, Carless M, Komorowski R, Nuttleman P, Andris D, Makladi B, Kleiner DE, Curran J, Dyer TD, Charlesworth J, Blangero J, Kissebah A, Olivier O. 2008. Discovery of gene networks involved in non-alcoholic fatty liver disease using genome-wide transcriptional profiling. Hepatology: 48(4): Supp 1, A811. Presented as a poster at AASLD meeting, San Francisco, CA - 2008.
14. Kwiatt J, Desai M, Gawrieh S, Saeian S. Use of a patient registry database to improve hepatocelluar carcinoma screening, vaccination rates, and esophageal varices screening in patients with cirrhosis. Gastroenterology 2009; 136 (Suppl 1):M1003.
15. Patel A, Gawrieh S, Rizvi S, Xiang X, Szabo A, Saeian K. Fatty Liver Disease: Survey of AASLD members. Gastroenterology 2009; (Suppl 1): A847.
16. Guichelaar M, Gawrieh S, Viker K, Krishnan A, Charlton M. RS738409GG Genotype of PNPLA3 in patients with medically complicated obesity-correlations with liver histology (NASH), insulin resistance and fibrinogen. Hepatology 2010; 52 (Suppl):T255.
17. Gawrieh S, Martin L, Komorowski R, Wallace J, Goldblatt M, Santoro J, Makladi B, Viker K, Kissebah A, Charlton M, Olivier M. A non-synonymous PNPLA3 gene variant is associated with nonalcoholic fatty liver disease severity in morbidly obese North Americans. Hepatology 2010;52 (Suppl):S637.
18. Gawrieh S, Ananthakrishnan A, Komorowski R, Wallace J, Goldblatt M, Makladi B, Kissebah A, Olivier M. Smaller APOB and LDL particle sizes in NAFLD: A possible link to increased cardiovascular risk? Hepatology 2010; 52 (Suppl):S656.
19. Baillargeon P, Komorowski R, Wallace J, Ulitsky A, Goldbladtt M, Gawrieh S. Liver Histopathology in Patients With Nonalcoholic Fatty Liver Disease and Obstructive Sleep Apnea. American Journal of Clinical Pathology 2010, 134:667.
20. Kwiatt J, Desai, P, Gawrieh, S, Saeian, K. Performance Feedback Impacts Quality Measures in the Management of Cirrhosis. Oral presentation DDW Chicago May 2011